Company Overview and News
The current economic backdrop is shaping up well for insurers as they are witnessing gradual improvement in interest rates along with substantially lower level of catastrophe loss and reduced tax (owing to a noteworthy tax reform effective Jan 1, 2018). These factors have also led to a promising performance in the first quarter of 2018 and augur well for an encouraging second quarter. Hence, we expect the insurance industry to continue with the momentum and deliver a better-than-expected show as the year progresses.
ALL PGR NGHC CNFR
The Finance sector is set to kick off its earnings season this week with major banks reporting quarterly results. Improving rate environment and tax cuts should continue to drive the sector’s performance. Per the Earnings Outlook, earnings for the sector are expected to increase 18.5% on 3.6% higher revenues. Insurers, an important component of the Finance sector, are shortly going to release their financial numbers.
UNM TMK TRV SLF PGR TMK CNO SLF ALL MFC MFC CB
A recent report by Insurance Information Institute stated that the 2018 Atlantic hurricane season is expected to be milder than the earlier forecast. This is a relief for insurers since they faced above-average catastrophe activity in 2017 and incurred billions in losses from claim costs.
NGHCP NGHCO GJT NGHCN ALL.PRB PGR ALL.PRC XL ALL.PRA ALL.PRF ALL.PRG ALL.PRD ACGL NGHCZ ALL.PRE ALL ARH.PRC NGHC XLGLF ARHPF CNFR
Gradual improvement in interest rates, substantially lower level of catastrophe loss, reduced tax (owing to a noteworthy tax reform effective Jan 1, 2018) and improving economy have resulted in a favorable first half performance and set the tone for an encouraging second half. We expect the insurance industry to continue with the momentum and deliver a better-than-expected show as the year progresses.
ALL ARGO ARGO PGR BRO
The market managed to stop Wednesday’s strong selloff with a respectable bounceback on Thursday, but, the issue still hangs in the balance. The volume behind the gain was modest, and the indices are still within easy reach of a technical breakdown.
ALL SHW REGN AMZN RAD WBA CVS
The largest holders of US car inventory, hands down, are the consumers themselves, who own 260 million personal vehicles.
WFC WFCNP WFC.WS BAC C WFC.PRL PGR WFC.PRJ WMT BAC WFC.PRT ALL WFC.PRR TGT WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ALL GJT ALL.PRB ALL.PRC ALL.PRA ALL.PRF ALL.PRG ALL.PRD ALL.PRE
The Allstate Corporation (ALL - Free Report) recently announced estimated pretax catastrophe loss of about $278 million or $220 million after tax for May 2018.
GJT ALL.PRB ALL.PRC ALL.PRA NMIH ALL.PRF ALL.PRG ALL.PRD ALL.PRE ALL FFIV HCJ Y HCI HCIIP
Investors looking for stocks in the Insurance - Property and Casualty sector might want to consider either Allstate (ALL - Free Report) or W.R. Berkley (WRB - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
AMN Healthcare Services, Inc. (AMN - Free Report) is a provider of healthcare workforce solutions and staffing services. The Zacks Consensus Estimate for its current year earnings has been revised 3.3% downward over the last 60 days.
GJT CRUS ALL.PRB ALL.PRC ALL.PRA ALL.PRF ALL.PRG ALL.PRD ALL.PRE ALL AMN SPG.PRJ AHS SPG BIP
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
BCS.PRD BCS BCS.PRC GJT DB BCS.PRA ALL.PRB PGR ALL.PRC GOOG ALL.PRA ALL.PRF ALL.PRG ALL.PRD ALL.PRE 83SF BCS.PR ALL 83SK GOOGL 47MC
Chicago, IL – June 8, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Merck (MRK - Free Report) , Occidental Petroleum (OXY - Free Report) , Capital One Financial (COF - Free Report) , Kimberly-Clark (KMB - Free Report) and Allstate (ALL - Free Report) .
COF.PRG COF.PRH COF-P TTWO COF.WS FIX COF.PRP COF LB KMB COF-D COF-C ALL COF-F BKNG UFPI MU PATK PETS OXY COF.PRC COF.PRD COF.PRF
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), Occidental Petroleum (OXY) and Capital One Financial (COF). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
COF.PRG APC COF.PRH COF-P COF.WS COF.PRP COF KMB JOE COF-D BRK.A COF-C ALL COF-F ES 7018 CME RSG OXY COF.PRC COF.PRD AEUA COF.PRF
With the second quarter of 2018 almost over, many of the top Wall Street firms we follow are making some changes to the lists of their high-conviction stock picks for clients. With the market showing volatility not seen in years, it makes sense to examine the lists and make some changes as the rest of the year could have additional volatility as the political and geopolitical cycle could prove to be very explosive component.
GJT ALL.PRB ALL.PRC ALL.PRA ALL.PRF ALL.PRG ALL.PRD VZA ALL.PRE ALL DHI KHC VZ
It has been about a month since the last earnings report for The Allstate Corporation (ALL - Free Report) . Shares have lost about 4% in that time frame.
ALL GJT ARRS ALL.PRB ALL.PRC ALL.PRA ALL.PRF ALL.PRG ALL.PRD ALL.PRE
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
2018-07-06 - Asif
Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...
Silicon Investor Message Boards
This table lists all message boards related to ALL / Allstate Corp. (The) on message board site Silicon Investor.
as of ET